Meag Munich Ergo’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,616	Closed	-$388K	–	514
2019 Q4	$388K	Sell	3,616 -11,178	-76%	-$1.2M	0.04%	314
2019 Q3	$1.44M	Buy	14,794 +6,323	+75%	+$713K	0.07%	284
2019 Q2	$1.07M	Hold	8,471	–	–	0.08%	247
2019 Q1	$1.13M	Sell	8,471 -1,541	-15%	-$192K	0.09%	233
2018 Q4	$985K	Buy	+10,012	New	+$1.18M	0.12%	245
2018 Q3	–	Sell	-10,449	Closed	-$1.28M	–	428
2018 Q2	$1.28M	Buy	+10,449	New	+$1.22M	0.08%	239
2018 Q1	–	Sell	-21,713	Closed	-$2.63M	–	525
2017 Q4	$2.63M	Sell	21,713 -18,756	-46%	-$2.28M	0.1%	242
2017 Q3	$5.62M	Buy	40,469 +14,956	+59%	+$2.03M	0.23%	132
2017 Q2	$3.12M	Buy	25,513 +1,107	+5%	+$129K	0.14%	176
2017 Q1	$2.97M	Buy	24,406 +480	+2%	+$61.9K	0.12%	208
2016 Q4	$2.97M	Buy	+23,926	New	+$2.93M	0.14%	180